ASMB
Assembly Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$463.51M
P/E Ratio
—
EPS
$-0.55
Beta
1.16
52W High
$39.71
52W Low
$7.90
50-Day MA
$28.04
200-Day MA
$27.16
Dividend Yield
—
Profit Margin
-8.47%
Forward P/E
21.10
PEG Ratio
0.00
About Assembly Biosciences Inc
Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $72.30M |
| Gross Profit (TTM) | $7.49M |
| EBITDA | $-11.99M |
| Operating Margin | 46.60% |
| Return on Equity | -5.10% |
| Return on Assets | -4.02% |
| Revenue/Share (TTM) | $6.45 |
| Book Value | $13.04 |
| Price-to-Book | 2.23 |
| Price-to-Sales (TTM) | 6.41 |
| EV/Revenue | 2.987 |
| EV/EBITDA | 0.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 477.30% |
| Shares Outstanding | $15.86M |
| Float | $7.50M |
| % Insiders | 32.21% |
| % Institutions | 60.10% |
Analyst Ratings
Consensus ($48.75 target)
3
BuyData last updated: 4/7/2026